BioNexus Gene Lab Corp. Increase (Decrease) in Deferred Revenue
BioNexus Gene Lab Corp. (BGLC) reported Increase (Decrease) in Deferred Revenue of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2024-04-16
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for the quarter ending 2023-12-31 was $0.00.
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for the quarter ending 2023-09-30 was $0.00.
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for the quarter ending 2023-06-30 was $0.00.
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for the quarter ending 2023-03-31 was $0.00.
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for fiscal 2023 was $0.00.
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for fiscal 2022 was -$77.28K, a 200.00% decline from fiscal 2021.
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for fiscal 2021 was $77.28K.
- BioNexus Gene Lab Corp. increase (decrease) in deferred revenue for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 10-K · filed 2024-04-16 |
| 2023-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $0.00 derived: sum of 2 quarters · filed 2024-03-26 | $0.00 10-Q/A · filed 2024-03-26 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $0.00 10-Q · filed 2023-08-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | $0.00 derived: sum of 4 quarters · filed 2024-04-16 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $0.00 derived: sum of 3 quarters · filed 2024-04-16 | -$77.28K 10-K · filed 2024-04-16 |
| 2022-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-03-26 | $0.00 derived: sum of 2 quarters · filed 2024-03-26 | -$77.28K 10-Q/A · filed 2024-03-26 | $0.00 derived: sum of 4 quarters · filed 2024-03-26 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | -$77.28K 10-Q · filed 2023-08-16 | $0.00 derived: sum of 3 quarters · filed 2023-08-16 | $0.00 derived: sum of 4 quarters · filed 2023-08-16 |
| 2022-03-31 | -$77.28K 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $0.00 derived: sum of 3 quarters · filed 2023-05-09 | $0.00 derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $77.28K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $77.28K derived: sum of 2 quarters · filed 2023-03-31 | $77.28K derived: sum of 3 quarters · filed 2023-03-31 | $77.28K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |